Literature DB >> 12957241

Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients.

R M'kacher1, T Girinsky, S Koscielny, J Dossou, D Violot, N Béron-Gaillard, V Ribrag, J Bourhis, A Bernheim, C Parmentier, P Carde.   

Abstract

PURPOSE: To study chromosomal abnormalities in 49 patients with Hodgkin's lymphoma (HL), before and after treatment and at several times during a 2-year period. METHODS AND MATERIALS: Simple chromosomal aberrations (CAs) and complex chromosomal rearrangements (CCRs) were counted in peripheral lymphocytes by painting of chromosomes 1, 3, and 4 (fluorescence in situ hybridization). A control population was composed of 20 healthy donors and 69 untreated cancer patients who had undergone various radiologic scans.
RESULTS: A greater frequency (p < 10(-4)) of spontaneous cytogenetic abnormalities was observed in untreated HL patients compared with the control populations. CCRs were observed exclusively in the HL population (p < 10(-4)). Chemotherapy was associated with a significant increase in the frequency of CAs (p < 10(-4)), according to the chemotherapy regimen (p = 0.002). Immediately after radiotherapy, a significant increase (p < 10(-4)) was observed in CAs according to the size of the irradiation field. Conversely, the significant increases in the frequency of CCRs observed after treatment did not correlate with the chemotherapy regimens, radiotherapy dose, or size of the irradiation field. The evolution of CAs vs. CCRs over time was also dissociated: during the follow-up of these patients, a significant decrease was observed in the frequency of CAs at 6 months and 1 and 2 years. In contrast, after an initial decrease for up to 6 months after treatment, the frequency of CCRs remained constant for up to 2 years.
CONCLUSION: Increased cytogenetic abnormalities were observed in untreated HL patients compared with the control populations. The greater frequency of cytogenetic abnormalities persisted in some patients. The presence of CCRs supports the concept of a unique genetic environment in HL patients that persists in response to potentially noxious treatments.

Entities:  

Mesh:

Year:  2003        PMID: 12957241     DOI: 10.1016/s0360-3016(03)00578-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

Review 1.  Frailty and aging in cancer survivors.

Authors:  Kirsten K Ness; Matthew D Wogksch
Journal:  Transl Res       Date:  2020-05-01       Impact factor: 7.012

2.  The kelch protein KLHDC8B guards against mitotic errors, centrosomal amplification, and chromosomal instability.

Authors:  Maxwell M Krem; Ping Luo; Brandon I Ing; Marshall S Horwitz
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

Review 3.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

Review 4.  Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

Authors:  María Sol Brassesco; Danilo Jordão Xavier; Marjori Leiva Camparoto; Ana Paula Montaldi; Paulo Roberto D'Auria Vieira de Godoy; Carlos Alberto Scrideli; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo
Journal:  J Biomed Biotechnol       Date:  2010-08-31

5.  Aurora B kinase in Hodgkin lymphoma: immunohistochemical pattern of expression in neoplastic Hodgkin and Reed-Sternberg cells.

Authors:  M Ioannou; E Kouvaras; E Stathakis; M Samara; G K Koukoulis
Journal:  J Mol Histol       Date:  2013-12-24       Impact factor: 2.611

6.  Mutations in a gene encoding a midbody protein in binucleated Reed-Sternberg cells of Hodgkin lymphoma.

Authors:  Maxwell M Krem; Stephen J Salipante; Marshall S Horwitz
Journal:  Cell Cycle       Date:  2010-03-02       Impact factor: 4.534

7.  Transmission of Induced Chromosomal Aberrations through Successive Mitotic Divisions in Human Lymphocytes after In Vitro and In Vivo Radiation.

Authors:  Akram Kaddour; Bruno Colicchio; Diane Buron; Elie El Maalouf; Eric Laplagne; Claire Borie; Michelle Ricoul; Aude Lenain; William M Hempel; Luc Morat; Mustafa Al Jawhari; Corina Cuceu; Leonhard Heidingsfelder; Eric Jeandidier; Georges Deschênes; Alain Dieterlen; Michèle El May; Theodore Girinsky; Annelise Bennaceur-Griscelli; Patrice Carde; Laure Sabatier; Radhia M'kacher
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

8.  Mitotic errors, aneuploidy and micronuclei in Hodgkin lymphoma pathogenesis.

Authors:  Maxwell M Krem; Marshall S Horwitz
Journal:  Commun Integr Biol       Date:  2013-05-13

Review 9.  Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.

Authors:  Corina Cuceu; William M Hempel; Laure Sabatier; Jacques Bosq; Patrice Carde; Radhia M'kacher
Journal:  Cancers (Basel)       Date:  2018-03-26       Impact factor: 6.639

10.  Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies.

Authors:  Radhia M'kacher; Monika Frenzel; Mustafa Al Jawhari; Steffen Junker; Corina Cuceu; Luc Morat; Anne-Laure Bauchet; Lev Stimmer; Aude Lenain; Nathalie Dechamps; William M Hempel; Geraldine Pottier; Leonhard Heidingsfelder; Eric Laplagne; Claire Borie; Noufissa Oudrhiri; Dima Jouni; Annelise Bennaceur-Griscelli; Bruno Colicchio; Alain Dieterlen; Theodore Girinsky; Raphael Boisgard; Jean Bourhis; Jacques Bosq; Thomas Mehrling; Eric Jeandidier; Patrice Carde
Journal:  Cancers (Basel)       Date:  2018-10-31       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.